Related Experiment Videos
[Side effects of immunomodulators and countermeasures]
Ryumachi. [Rheumatism]
|December 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2015
Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases.
Clinical and experimental obstetrics & gynecology·2014
Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis.
Clinical and experimental rheumatology·2011
Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
A foodborne outbreak of a group A streptococcal infection in a Japanese university hospital.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2008
Cancer targets in the Ras pathway.
Cold Spring Harbor symposia on quantitative biology·2006
[Hemophagocytic syndrome associated with hypercytokinemia in a patients with rheumatoid arthritis].
Ryumachi. [Rheumatism]·2003
[Case of vascular Behçet's disease initially presented with Bürger's disease-like vasculitides].
Ryumachi. [Rheumatism]·2003
[A case of psoriatic arthropathy complicated with HTLV-I carrier and secondary amyloidosis].
Ryumachi. [Rheumatism]·2003
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026